AI & Imaging
Lunit DBT update adds prior-exam comparison for breast AI
Version 1.2 of Lunit INSIGHT DBT adds current-prior comparison, selectable operating thresholds, and access to Volpara Scorecard density measures.
Company
Lunit
South Korean medical AI company headquartered in Seoul, developing AI software for cancer detection and precision oncology, including chest X-ray and mammography solutions. Lunit acquired Volpara Health in 2024 to expand its breast cancer screening footprint.